ATOSSA THERAPEUTICS, INC. 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-276160
- Form type
- 10-Q
- CIK
- 0001488039
- Primary document
- https://www.sec.gov/Archives/edgar/data/1488039/000119312525276160/atos-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ATOSSA THERAPEUTICS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-25.7M | - | - |
| Net Income | $-23.8M | - | - |
| Eps Basic | -0.18 | - | - |
| Eps Diluted | -0.18 | - | - |
| Cash And Equivalents | $51.8M | - | - |
| Total Assets | $58.0M | - | - |
| Total Liabilities | $8.2M | - | - |
| Shareholders Equity | $49.8M | - | - |
| Operating Cash Flow | $-19.2M | - | - |
| Capital Expenditures | $16,000 | - | - |